The objective of this Core Unit is to provide a cental mechanism to assist investigators with the design and execution of hematopoietic stem cell transduction studies in the baboon. The Core Unit will provide three main functions. 1) The design and the planning of the baboon experiments. The Unit will ensure that baboons will be available and adequately prepared for the individual studies. 2) The marrow harvest and the reinfusion of transduced cells. Marrow will be harvested from femura and humeri and given to Core Unit B for CD34 separations and then to the individual investigators for transduction. Before reinfusion of transduced cells the animals will receive a myeloablative dose of total body irradiation. All animals will receive an intravenous catheter that is connected via a tether system to the outside of the cage. This facilitates the daily administration of fluids and broad-spectrum antibiotics and will also be used for reinfusion of transduced baboon CD34 cells. 3) The post-transplant monitoring and care of the animals and obtaining the blood samples and bone marrow samples required for the studies. All animals will be examine daily by the Core Unit directors and health status and treatment plan will be discussed with specially trained personnel at the Primate Center. The directors of this ore Unit have extensive experience in conducting stem cell transplantation studies in the baboon. The Primate Center at the University of Washington has set aside a special room for our baboon studies to accommodate the intensive care required for these studies and the staff at the Primate Center is specially trained to work with baboons involved in stem cell transplantation studies. In many ways, the operation of this baboon stem cell unit is modeled after a human stem cell transplantation unit to assure the high quality care required for these studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL053750-07
Application #
6346232
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2000
Total Cost
$223,393
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Constantinou, Varnavas C; Bouinta, Asimina; Karponi, Garyfalia et al. (2017) Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with ?-thalassemia major. Transfusion 57:1031-1039
Gori, Jennifer L; Butler, Jason M; Kunar, Balvir et al. (2017) Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates. Stem Cells Transl Med 6:864-876
Psatha, Nikoletta; Karponi, Garyfalia; Yannaki, Evangelia (2016) Optimizing autologous cell grafts to improve stem cell gene therapy. Exp Hematol 44:528-39
Li, Li B; Ma, Chao; Awong, Geneve et al. (2016) Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther 24:582-91
Karponi, Garyfalia; Psatha, Nikoletta; Lederer, Carsten Werner et al. (2015) Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy. Blood 126:616-9
Vierstra, Jeff; Reik, Andreas; Chang, Kai-Hsin et al. (2015) Functional footprinting of regulatory DNA. Nat Methods 12:927-30
Qi, Heyuan; Liu, Mingdong; Emery, David W et al. (2015) Functional validation of a constitutive autonomous silencer element. PLoS One 10:e0124588
Liu, Mingdong; Maurano, Matthew T; Wang, Hao et al. (2015) Genomic discovery of potent chromatin insulators for human gene therapy. Nat Biotechnol 33:198-203
Polak, Paz; Karli?, Rosa; Koren, Amnon et al. (2015) Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518:360-364
Watts, Korashon L; Beard, Brian C; Wood, Brent L et al. (2014) No evidence of clonal dominance after transplant of HOXB4-expanded cord blood cells in a nonhuman primate model. Exp Hematol 42:497-504

Showing the most recent 10 out of 161 publications